智能聚合框架 (SAF):用于揭示原子重要性排名和提高药物发现预测率的智能聚合框架
1Department of Physiology, Biophysics & Systems Biology, Medicine Faculty, Technion IIT, Haifa 3525422, Israel.
Journal of chemical information and modeling
|May 2, 2024
概括
这项研究引入了一种用于药物发现中的图形神经网络的新型加权聚合方法. 它增强了抗生素活性预测,并为可解释的机器学习模型提供了受管制的注意力机制.
科学领域:
- 计算化学是一种计算化学.
- 机器学习是机器学习.
- 药物发现 药物发现
背景情况:
- 机器学习,特别是代表性学习,对in silico药物发现有希望.
- 图形神经网络 (GNN) 将分子表示为图形,但聚合原子信息带来了挑战.
- 现有的聚合方法,如平均值,可以导致原子层面的信息丢失.
研究的目的:
- 为分子表示中GNN开发一种新的非线性加权聚合方法.
- 提高使用GNN的抗生素活性预测准确度.
- 引入一个受监管的注意力机制,以提高GNN的可解释性.
主要方法:
- 提出了一种非线性加权聚合方法,使用波尔兹曼分布与类似温度的超参数.
- 将这种方法应用于传递信息的神经网络 (MPNN) 以预测抗生素活性.
- 通过分析其识别重要原子和功能组的能力来验证该方法.
主要成果:
- 与标准聚合相比,加权聚合方法显著改善了对抗生素活性的预测.
- 温度超参数提供了一种流而一致的方式来识别活动预测至关重要的原子.
- 该方法成功地回顾了β-乳糖抗生素中已知的功能组.
结论:
- 新的加权聚合方法提高了GNN在药物发现任务中的性能.
- 这种方法为GNN提供了一个强大的,可解释的注意力机制,有助于理解分子对活动的贡献.
- 该方法在任何GNN中具有广泛的适用性,用于提供节点级解释性.
更多相关视频
16:02Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
Published on: February 10, 2023
2.7K
10:21Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
2.5K
相关概念视频
Structure-Activity Relationships and Drug Design
708
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
708
Drug Discovery: Overview
7.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.8K
Agonism and Antagonism: Quantification
366
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
366
